Clinical trial
OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity
NCT02145676 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity
- Lead sponsor
- Allergan
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- May 31, 2014
- Completion date
- December 31, 2015
- Enrollment
- 53 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.